Publications by authors named "A Ploss"

Article Synopsis
  • * There are over 50 flavivirus species, many previously exotic to humans, with the potential for emerging diseases, as seen in past outbreaks of Zika and West Nile viruses.
  • * The review focuses on mosquito-borne flaviviruses that can cause serious diseases in animals and potentially humans, exploring their pathology, animal models for study, and future research directions, including emerging threats like Usutu and Murray Valley encephalitis viruses.
View Article and Find Full Text PDF

Though interferons (IFNs) were once heralded as panaceas to numerous diseases, how cells decode varying IFN stimuli and subsequently produce (in)appropriate signaling remain unclear. Our labs recently engineered novel erythropoietin receptor-IFN chimeric receptors, and we highlight their utility in two cases uncovering differential genetic determinants of type I (IFN-α/β) and type III (IFN-λ) IFN signaling. These and other types of synthetic (cytokine) receptors could be expanded to real-time signaling dynamics and studies.

View Article and Find Full Text PDF

Modification of RNA with N-methyladenosine (mA) has gained attention in recent years as a general mechanism of gene regulation. In the liver, mA, along with its associated machinery, has been studied as a potential biomarker of disease and cancer, with impacts on metabolism, cell cycle regulation, and pro-cancer state signaling. However these observational data have yet to be causally examined For example, neither perturbation of the key mA writers and , nor the mA readers and have been thoroughly mechanistically characterized as they have been .

View Article and Find Full Text PDF

Hepatitis E virus (HEV) is a long-neglected RNA virus and the major causative agent of acute viral hepatitis in humans. Recent data suggest that HEV has a very heterogeneous hypervariable region (HVR), which can tolerate major genomic rearrangements. In this study, we identify insertions of previously undescribed sequence snippets in serum samples of a ribavirin treatment failure patient.

View Article and Find Full Text PDF